Article citationsMore>>

[1] Saif, M.W. and Reardon, J. (2005) Management of oxaliplatin-induced peripheral neuropath. Journal of Therapeutics and Clinical Risk Management, 1, 249-258.

has been cited by the following article:

• TITLE: Oxaliplatin induced hyperexcitability syndrome in patient with appendiceal adenocarcinoma

  AUTHORS: Nicola Jabbour, Maher Alchreiki, Mohammad Hussain

  KEYWORDS: Oxaliplatin; Peripheral Neuropathy; Neuromyotonia; Hyperexcitability Syndrome; Appendiceal Adenocarcinoma; Sodium Channels

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.2 No.4, July 8, 2013

  ABSTRACT: Oxaliplatin is a novel platinum compound with clinical activity against several solid tumors. It has been associated with sensory neuropathies and, rarely, a neuromyotonia-like hyperexcitability syndrome; a form of peripheral neuropathy manifested by tremor and twitching activity of muscles. We present a case of hyperexcitability syndrome developed during the treatment of stage III appendiceal adenocarcinoma with oxaliplatin-containing regimen and was successfully treated with Pregabalin.